BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2570378)

  • 1. Presynaptic auto- and allelo-receptor regulation of hypothalamic opioid peptide release.
    Nikolarakis KE; Almeida OF; Yassouridis A; Herz A
    Neuroscience; 1989; 31(1):269-73. PubMed ID: 2570378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity of various opioid peptides towards delta-, kappa; and mu-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain.
    Mulder AH; Wardeh G; Hogenboom F; Frankhuyzen AL
    Neuropeptides; 1989; 14(2):99-104. PubMed ID: 2573000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S; Kim HS; Wood PL
    Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroanatomical sites mediating the central actions of beta-endorphin as mapped by changes in glucose utilization: involvement of mu opioid receptors.
    Ableitner A; Schulz R
    J Pharmacol Exp Ther; 1992 Jul; 262(1):415-23. PubMed ID: 1352555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin.
    Wu HE; Hung KC; Mizoguchi H; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2002 Feb; 300(2):647-54. PubMed ID: 11805228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central delta-opioid receptor interactions and the inhibition of reflex urinary bladder contractions in the rat.
    Dray A; Nunan L; Wire W
    Br J Pharmacol; 1985 Jul; 85(3):717-26. PubMed ID: 2992671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prenatal development profile of expression of opioid peptides and receptors in the mouse brain.
    Rius RA; Barg J; Bem WT; Coscia CJ; Loh YP
    Brain Res Dev Brain Res; 1991 Feb; 58(2):237-41. PubMed ID: 1674235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of hypothalamic opioid peptide release by lithium is mediated by opioid autoreceptors: evidence from a combined in vitro, ex vivo study.
    Burns G; Herz A; Nikolarakis KE
    Neuroscience; 1990; 36(3):691-7. PubMed ID: 2172862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic opioid kappa-receptor and regulation of the release of Met-enkephalin in the rat brainstem.
    Ueda H; Fukushima N; Ge M; Takagi H; Satoh M
    Neurosci Lett; 1987 Oct; 81(3):309-13. PubMed ID: 2829060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally administered beta-endorphin produces prolonged changes in delta-opioid ligand activity in vivo.
    Dray A; Nunan L; Wire W
    Eur J Pharmacol; 1986 Jan; 120(3):359-62. PubMed ID: 3005007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of opioid peptides on circular muscle of canine duodenum.
    Bauer AJ; Szurszewski JH
    J Physiol; 1991 Mar; 434():409-22. PubMed ID: 1673718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.